BioID-based proteomic analysis of the Bid interactome identifies novel proteins involved in cell-cycle-dependent apoptotic priming.

Cell Death Dis

Wellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.

Published: October 2020


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Apoptotic priming controls the commitment of cells to apoptosis by determining how close they lie to mitochondrial permeabilisation. Variations in priming are important for how both healthy and cancer cells respond to chemotherapeutic agents, but how it is dynamically coordinated by Bcl-2 proteins remains unclear. The Bcl-2 family protein Bid is phosphorylated when cells enter mitosis, increasing apoptotic priming and sensitivity to antimitotic drugs. Here, we report an unbiased proximity biotinylation (BioID) screen to identify regulators of apoptotic priming in mitosis, using Bid as bait. The screen primarily identified proteins outside of the canonical Bid interactome. Specifically, we found that voltage-dependent anion-selective channel protein 2 (VDAC2) was required for Bid phosphorylation-dependent changes in apoptotic priming during mitosis. These results highlight the importance of the wider Bcl-2 family interactome in regulating the temporal control of apoptotic priming.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567853PMC
http://dx.doi.org/10.1038/s41419-020-03091-8DOI Listing

Publication Analysis

Top Keywords

apoptotic priming
24
bid interactome
8
bcl-2 family
8
priming mitosis
8
priming
7
apoptotic
6
bid
5
bioid-based proteomic
4
proteomic analysis
4
analysis bid
4

Similar Publications

Acute myeloid leukemia (AML) is a heterogeneous disease characterized by a broad spectrum of molecular alterations that influence clinical outcomes. mutations define one of the most lethal subtypes of acute myeloid leukemia (AML), driving resistance to nearly all available treatment modalities, including venetoclax plus azacitidine (VenAza). Yet, the molecular basis of this resistance, beyond affecting transactivation of BCL-2 family genes, has remained elusive.

View Article and Find Full Text PDF

Resistance to the Bcl-2-specific inhibitor, Venetoclax (VEN), poses a therapeutic challenge in the management of chronic lymphocytic leukemia and acute myeloid leukemia. Although VEN resistance has been linked to Mcl-1 upregulation, thereby switching survival dependence from Bcl-2 to Mcl-1, the mechanism underlying increased Mcl-1 expression remains elusive. Given that changes in cellular redox state affect cancer cell fate, we investigated the crosstalk between intracellular redox milieu and Mcl-1 upregulation in VEN-resistant cells.

View Article and Find Full Text PDF

Microplastics (MPs), particularly those exceeding 20 μm in diameter, are increasingly detected in environment and animal tissues, yet their cytotoxicity remains poorly understood. While existing studies focused on MPs with relatively small sizes (≤ 20 μm) or nanoplastics (NPs), the biological impacts of large-sized MPs and amino-modified MPs are underexplored. In this study, we investigated the oxidative stress (OS)-mediated responses of alpha mouse liver 12 (AML12) cells to 50 μm polystyrene MPs (PS-MPs) and polystyrene-amine modified MPs (PS-NH-MPs) at concentrations of 0, 0.

View Article and Find Full Text PDF

Exploring the mechanism of action of trastuzumab-induced cardiomyocyte atrophy based on the FN1/PI3K/AKT-mediated mTOR-independent signaling pathway.

Genomics

July 2025

Department of Pharmacy, the First Affiliated Hospital of Soochow University, Suzhou, China; Department of Pharmacology, Soochow University, Suzhou, China. Electronic address:

Trastuzumab (TRZ) is a standard drug for the treatment of HER-2-positive breast cancer, but its cardiotoxicity seriously affects the prognosis of patients, and the potential mechanism of TRZ-induced cardiomyocyte atrophy leading to cardiotoxicity remains unclear. This study aimed to investigate the potential targets and signaling pathways of TRZ-induced cardiotoxicity using single-cell transcriptome sequencing (scRNA-seq) and bioinformatics methods. A total of 618 differentially expressed genes (DEGs) were identified through scRNA-seq and bioinformatics analysis.

View Article and Find Full Text PDF

Paclitaxel and other microtubule-targeting agents are cornerstone therapies for diverse cancers, including lung, breast, cervical, pancreatic, and ovarian malignancies. Paclitaxel induces tumor cell apoptosis during mitosis by disrupting microtubule dynamics required for chromosome segregation. However, despite initial responsiveness, many tumors develop resistance, limiting therapeutic durability.

View Article and Find Full Text PDF